Clinical Study of Bowel Preparation Before Colonoscopy (NCT06091735) | Clinical Trial Compass
CompletedNot Applicable
Clinical Study of Bowel Preparation Before Colonoscopy
China444 participantsStarted 2023-08-01
Plain-language summary
This study was a single-center, randomized controlled clinical study. Subjects meeting the inclusion criteria will be randomly assigned to magnesium sodium potassium sulfate oral concentrated solution group, magnesium sodium potassium sulfate oral concentrated solution + linaclotide group, PEG group in equal proportion.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Signed written informed consent;
* Age 18-80 years old, gender is not limited;
* The subjects could follow the follow-up plan, objectively describe the symptoms, and cooperate with the completion of the scale;
* Non-lactating pregnant women and no pregnancy plan during the test;
* Do not participate in any clinical trials for 3 months before and during the trial;
* Participate voluntarily and sign informed consent.
Exclusion Criteria:
* NYHA cardiac function grade III or IV;
* Unstable angina pectoris in the convalescence period of acute myocardial infarction or in the near future;
* have serious liver and kidney function diseases;
* Suspected gastrointestinal obstruction or gastrointestinal perforation;
* Pregnant or lactating women;
* Mental illness or physical dysfunction can not cooperate with the examination;
* People who are allergic to intestinal preparation drugs.
* Patients who did not undergo colonoscopy after bowel clearing due to their own reasons;
* Patients who can not tolerate general colonoscopy and terminate the examination;
* Patients who requested withdrawal from the study.